Litcius/Paper detail

LBA0001 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

Daniël Blockmans, Steven Penn, A. Setty, Wolfgang Schmidt, Andrea Rubbert‐Roth, E.M. Hauge, Helen Keen, Tomonori Ishii, Nader Khalidi, Mei Liu, W. Zhao, I. Lagunes, Alfonso E. Romero, Peter Wung, Peter A. Merkel

2024Annals of the Rheumatic Diseases13 citationsDOI

Topics & Concepts

Giant cell arteritisDouble blindMedicineRandomized controlled trialInternal medicineVasculitisPathologyAlternative medicineDiseasePlaceboVasculitis and related conditionsCoagulation, Bradykinin, Polyphosphates, and AngioedemaOtitis Media and Relapsing Polychondritis
LBA0001 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL | Litcius